secwatch / observer

Elite Health Systems Inc. — fact timeline

Source-grounded facts extracted from Elite Health Systems Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.

EHSI Elite Health Systems Inc. JSON
Governance Changes

Elite Health Systems Inc.: Amended certificate of incorporation to change company name from U.S. Neurosurgical Holdings, Inc. to Elite Health Systems Inc (effective 2024-09-30).

“On September 30, 2024, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Charter Amendment”) to its Certificate of Incorporation (as amended, the “Charter”) to change the legal name of the Company from U.S, Neurosurgical Holdings, Inc. to Elite Health Systems Inc., effective as of September 30, 2024.”

Dr. Prasad A. Jeereddi was appointed as Chief Executive Officer at Elite Health Systems Inc..

“the Board unanimously appointed Dr. Prasad A. Jeereddi, age 76, Chief Executive Officer of the Company”

Alan Gold resigned as President at Elite Health Systems Inc..

“Mr. Alan Gold resigned from his positions as President of the Company, effective immediately.”

Charles H. Merriman resigned as Director at Elite Health Systems Inc..

“Mr. Charles H. Merriman resigned from his position as a member of the Board and from all of its committees.”
Material Agreements

Elite Health Systems Inc. entered into Private Placement with certain accredited investors valued at $1,000,000 (effective 2024-01-16).

“On January 16, 2024, U.S. NeuroSurgical Holdings, Inc. (“USNU” or the “Company”), held an initial closing (the “Initial Closing”) of a private placement of shares of the Company’s common stock for gross proceeds of not less than $1,000,000 and up to $2,000,000 at a price per share of $0.50 per share (“Private Placement”). With the Initial Closing, the Company raised proceeds of $1,000,000”
Material Agreements

Elite Health Systems Inc. entered into Share Exchange Agreement with holders of minority interests in U.S. NeuroSurgical, Inc. valued at 1,392,739 newly-issued shares of USNU common stock, representing 15% of the Company's outstanding co (effective 2023-11-27).

“U.S. NeuroSurgical Holdings, Inc. (“USNU” or the “Company”), entered into a Share Exchange Agreement dated as of November 27, 2023 (the “Share Exchange Agreement”) with the holders of minority interests in U.S. NeuroSurgical, Inc. (“USN”), which resulted in making USN a wholly-owned subsidiary of the Company.”

William St. Lawrence was appointed as non-executive director at Elite Health Systems Inc..

“On April 17, 2023, the Board of Directors (the “Board”) of U.S. NeuroSurgical Holdings, Inc., a Delaware corporation, (“Company”) unanimously appointed Mr. William St. Lawrence, age 53, as a non-executive director of the Company’s Board, effective immediately.”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.